Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
October 01, 2020
C4 Therapeutics Announces Pricing of an Upsized Initial Public Offering
READ MORE
September 08, 2020
Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics
READ MORE
July 15, 2020
C4 Therapeutics Announces the Additions of William McKee as Chief Financial Officer and Jolie M. Siegel as Chief Legal Officer
READ MORE
June 16, 2020
C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform
READ MORE
June 16, 2020
C4 Therapeutics raises $170 million to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept
READ MORE
January 13, 2020
Geneoscopy’s Preventive Screening Test for Colorectal Cancer and Precancerous Adenomas Earns FDA Breakthrough Device Designation
READ MORE
October 02, 2019
Geneoscopy Raises $6.9 million to Advance Preventive Screening Test for Colorectal Cancer
READ MORE
September 23, 2019
C4 Therapeutics Announces the Addition of Ryan B. Corcoran, M.D., Ph.D. to the Scientific Advisory Board
READ MORE
April 30, 2019
Wugen Adds to Leadership Team as Company Continues to Lay Groundwork for Future Expansion
READ MORE
March 26, 2019
WUGEN Expands Leadership Team with Appointment of a Vice President of Research and Development and a Vice President of Product Development
READ MORE
1
17
18
19
20
21
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2021 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group